Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,248
datasets available to search
ShareScore release 0.9.0
Dataset results
2,248 results for “squamous cell carcinoma”
Stereotactic Post-operative Radiotherapy for Intraparotid Metastatic Cutaneous Squamous Cell Carcinoma
ClinicalTrials.gov study NCT07337161. IPD Sharing: UNDECIDED. Countries: 1. Publications: 34.
Identification of Individual Histological and Blood Markers in Patients With Recurrent or Metastatic Upper Aerodigestive Tract Squamous Cell Carcinoma in Response to Immunotherapies
ClinicalTrials.gov study NCT06061705. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Evaluation of Bintrafusp Alfa in Operable and Untreated Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04428047. IPD Sharing: NO. Countries: 1. Publications: 1.
Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT01737008. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of 3-Dimensional Conformal Radiotherapy (3D-CRT) Versus Intensity Modulated Radiotherapy (IMRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
ClinicalTrials.gov study NCT00652613. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M S
ClinicalTrials.gov study NCT01911598. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03082534. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of MK-3475 (Pembrolizumab) in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Treatment With Platinum-based and Cetuximab Therapy (MK-3475-055/KEYNOTE-055)
ClinicalTrials.gov study NCT02255097. IPD Sharing: YES. Countries: 0. Publications: 4.
A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma
ClinicalTrials.gov study NCT03519295. IPD Sharing: NO. Countries: 1. Publications: 2.
Exploring the Optimal Timing of Minimally Invasive Surgery for Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06364566. IPD Sharing: NO. Countries: 1. Publications: 24.
Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)
ClinicalTrials.gov study NCT00623558. IPD Sharing: Not stated. Countries: 1. Publications: 1.
De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT04638465. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety of Endoscopic Submucosal Tunnel Dissection for Superficial Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03404921. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03660449. IPD Sharing: NO. Countries: 1. Publications: 18.
A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02409186. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose Escalation Study of Hyperbaric Oxygen With Radiation and Chemotherapy to Treat Squamous Cell Carcinoma of the Head and Neck
ClinicalTrials.gov study NCT00474825. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ramucirumab + Pembrolizumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
ClinicalTrials.gov study NCT03650764. IPD Sharing: YES. Countries: 1. Publications: 1.
Postoperative Radiotherapy for Oral Squamous Cell Carcinoma After Neoadjuvant Therapy and Surgery
ClinicalTrials.gov study NCT05455632. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT02969473. IPD Sharing: Not stated. Countries: 1. Publications: 19.
Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT06912074. IPD Sharing: NO. Countries: 1. Publications: 12.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.